Clinical efficiency of primary coronary stenting and its impact on the prognosis of ST-segment elevation inferior left ventricular infarction with and without right ventricular involvement

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Adamian K.G.

NII kardiologii, Erevan, Armeniia

Aĭrapetian G.G.

Meditsinskiĭ tsentr "Érebuni", Erevan, Respublika Armeniia

Clinical efficiency of primary coronary stenting and its impact on the prognosis of ST-segment elevation inferior left ventricular infarction with and without right ventricular involvement

Authors:

Adamian K.G., Aĭrapetian G.G.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2013;16(2): 39‑44

Views: 628

Downloaded: 4

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Adamian KG, Aĭrapetian GG. Clinical efficiency of primary coronary stenting and its impact on the prognosis of ST-segment elevation inferior left ventricular infarction with and without right ventricular involvement. Russian Journal of Preventive Medicine. 2013;16(2):39‑44. (In Russ.)

Close metadata

The authors investigated the impact of primary coronary stenting on the early and late prognosis of ST-segment elevation inferior left ventricular infarction with and without right ventricular involvement. In the primary coronary stenting group, as compared to the medical treatment group, the risk of in-hospital death, early postinfarction angina, and cardiogenic shock reduced by 7.9% (p<0.05), 12.1% (p<0.01), and 6% (p<0.05), respectively. Among the patients without diabetes mellitus, as compared to the medical treatment group, primary coronary stenting reduced annual mortality and rehospitalization rates by 12.9 and 16.5%, respectively (p<0.01 in both cases). The impact of primary coronary stenting on mortality and morbidity rates was more marked in the presence of right left ventricular infarction.

Keywords:

myocardial infarction

right ventricle

primary coronary stenting

prognosis

Authors:

Adamian K.G.

NII kardiologii, Erevan, Armeniia

Aĭrapetian G.G.

Meditsinskiĭ tsentr "Érebuni", Erevan, Respublika Armeniia

List of references:

Graham I., Atar D., Borch-Johnsen K. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007; 28: 19: 2375-2414.
Haddad F., Doyle R., Murphy D.J., Hunt S.A. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008; 117: 13: 1717-1731.
Larose E., Ganz P., Reynolds H.G., Dorbala S., Di Carli M.F., Brown K.A., Kwong R.Y. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol 2007; 49: 8: 855-862.
Adamyan K.G., Airapetyan G.G. Vliyanie vovlecheniya miokarda pravogo zheludochka na klinicheskoe techenie, prognoz i ergometricheskie parametry pri ostrom infarkte miokarda levogo zheludochka s elevatsiei ST segmenta. Med nauka Armenii NAN RA 2010; 4: 86-89.
Alter D., Naylor C.D., Austin P.C., Tu J.V. Long-term MI outcomes at hospitals with or without on-site revascularization. JAMA 2001; 285: 16: 2101-2108.
Stukel T., Lucas F., Wennberg D. Long-term outcomes of regional variations in intensity of invasive vs medical management of Medicare patients with acute myocardial infarction. JAMA 2005; 293: 1329-1337.
Smith S.C. Jr, Collins A., Ferrari R., Holmes D.R. Jr, Logstrup S., McGhie D.V., Ralston J., Sacco R.L., Stam H., Taubert K., Wood D.A., Zoghbi W.A., World Heart Federation; American Heart Association; American College of Cardiology Foundation; European Heart Network; European Society of Cardiology. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001; 103: 24: 3019-3041.
Alpert J., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 3: 959-969.
Zeymer U., Neuhaus K. Thrombolysis and percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. Z Kardiol 2000; 89: Suppl 4: 30-40.
Cucherat M., Bonnefoy E., Tremeau G. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction. Cochrane Database Syst Rev 2003; 3: CD001560.
Ratcliffe A., Pepper C. Thrombolysis or primary angioplasty? Reperfusion therapy for myocardial infarction in the UK. Postgrad Med J 2008; 84: 73-77.
Nielsen P.H., Maeng M., Busk M., Mortensen L.S., Kristensen S.D., Nielsen T.T., Andersen H.R.; DANAMI-2 Investigators. Primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the Danish acute myocardial infarction 2 trial. Circulation 2010; 121: 13: 1484-1491.
Zijlstra F. Angioplasty vs thrombolysis for acute myocardial infarction: a quantitative overview of the effects of interhospital transportation. Eur Heart J 2003; 24: 1: 21-23.
Pintarić H., Nikolić-Heitzler V., Mihatov S., Vukosavić D., Lukenda J., Radić B., Starcević B., Zigman M., Sharma M. Dominant right ventricular infarction: is angioplasty the optimal therapeutic approach? Acta Med Australia 2001; 28: 5: 129-134.
Keeley E., Boura J., Grines C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 9351: 13-20.

Close metadata

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.